Discover
BRTX
BioRestorative Therapies, Inc.
1.91
30 x 0.35
2 x 0.26
bid
ask
+
0.02
1.06%
16 @ 04:00 PM
1.90 -0.01 (0.52%)
| Ytd | 63.25% | |
| 1y | 14.37% |
1.85
day range
1.93
0.14
52 week range
4.94
| Open | 1.92 | Prev Close | 1.89 | Low | 1.85 | High | 1.93 | Mkt Cap | 2.64M |
| Vol | 18.44K | Avg Vol | 26.05K | EPS | -21.40 | P/E | N/A | Forward P/E | -0.90 |
| Beta | 0.94 | Short Ratio | 1.95 | Inst. Own | 13.74% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 3.37 | 200-d Avg | 8.04 | 1yr Est | 13.00 |
| Income Statement | |||
| Total Revenue | 23.17K | ||
| Revenues (USD) | 23.17K | ||
| Cost of Revenue | 7.39K | ||
| Gross Profit | 15.79K | ||
| Operating Expenses | 3.40M | ||
| Research and Development Expense | 1.93M | ||
| Selling, General and Administrative Expense | 1.48M | ||
| Operating Income | -3.39M | ||
| Net Income | -2.15M | ||
| Net Income Common Stock | -2.15M | ||
| Net Income Common Stock (USD) | -2.15M | ||
| Consolidated Income | -2.15M | ||
| Earnings per Basic Share | -2.40 | ||
| Earnings per Basic Share (USD) | -2.40 | ||
| Earnings per Diluted Share | -2.40 | ||
| Earning Before Interest & Taxes (EBIT) | -2.15M | ||
| Earning Before Interest & Taxes (USD) | -2.15M | ||
| Weighted Average Shares | 886.39K | ||
| Weighted Average Shares Diluted | 886.39K | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.11M | ||
| Cash and Equivalents (USD) | 3.11M | ||
| Investments | 479.35K | ||
| Investments Current | 479.35K | ||
| Trade and Non-Trade Receivables | 13.30K | ||
| Current Assets | 3.80M | ||
| Property, Plant & Equipment Net | 328.81K | ||
| Total Assets | 4.64M | ||
| Current Liabilities | 1.61M | ||
| Total Liabilities | 1.61M | ||
| Accumulated Retained Earnings (Deficit) | -172.08M | ||
| Shareholders Equity | 3.03M | ||
| Shareholders Equity (USD) | 3.03M | ||
| Assets Non-Current | 840.57K | ||
| Goodwill and Intangible Assets | 511.76K | ||
| Trade and Non-Trade Payables | 666.90K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 52.39K | ||
| Net Cash Flow from Financing | 4.44M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.60M | ||
| Issuance (Purchase) of Equity Shares | 5.00M | ||
| Net Cash Flow from Investing | 968.45K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 968.45K | ||
| Net Cash Flow from Operations | -3.81M | ||
| Share Based Compensation | 290.21K | ||